... Cristina Beza, Daniela Ugliettia, Federica Demarosia, Giovanni Lodia, Andrea Sardellaa, Sonia... more ... Cristina Beza, Daniela Ugliettia, Federica Demarosia, Giovanni Lodia, Andrea Sardellaa, Sonia Viscardia, Antonio Carrassia ... The diagnosis of BMS was based on a patient's symptoms referred to as: spontaneous burning, sting-ing or itching sensation, oral dryness, oral ...
... In numerose riviste sono pub-blicate le linee guida di tale pro-filassi, riportate estesament... more ... In numerose riviste sono pub-blicate le linee guida di tale pro-filassi, riportate estesamente anche sul British National For-mulary e sulla sua edizione ita-liana, curata dall'Agenzia Italia-na del Farmaco (8). ... endocarditis, prosthetic valves and pulmonary or systemic shunts. ...
Oral mucositis is one of the most frequent and significant complications in patients undergoing b... more Oral mucositis is one of the most frequent and significant complications in patients undergoing bone marrow transplantation (BMT). 1 Many agents of differing mechanisms of action 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ...
Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1999
Objective. The aim of this open trial was to test the efficacy of granulocyte-macrophage colony-s... more Objective. The aim of this open trial was to test the efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthrinses as a potential treatment in reducing the duration of severe oral mucositis in patients undergoing bone marrow transplantation for hematologic malignancies. Study Design. The study group was composed of 10 consecutive patients suffering from severe oral mucositis during bone marrow transplantation procedures.
... riesgo. AGRADECIMIENTOS. Los revisores desean agradecer a Chiara Procchio por su ayuda durant... more ... riesgo. AGRADECIMIENTOS. Los revisores desean agradecer a Chiara Procchio por su ayuda durante la mayor parte del trabajo. A Elena Telaro, Emma Tavender, Helen Worthington y Marco Esposito por su apoyo continuo. A ...
... Lodi, DDS, PhD; Antonio Carrassi, MD Milano. 1. Hiroki A, Nakamura S, Shinohara M, et al. Sig... more ... Lodi, DDS, PhD; Antonio Carrassi, MD Milano. 1. Hiroki A, Nakamura S, Shinohara M, et al. Significance of oral examination in chronic graft-versus-host disease. Oral Pathol Med. 1994;23:209-215. FULL TEXT | WEB OF SCIENCE | PUBMED. 2. Schubert MM, Sullivan KM. ...
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2015
This systematic review aimed to (1) explore the patient-reported outcome measures (PROMs) current... more This systematic review aimed to (1) explore the patient-reported outcome measures (PROMs) currently used in the oral mucosal disease literature and report on the type and context of the use of these instruments and (2) provide a future direction for PROMs in Oral Medicine practice and research. A systematic review of published English-language articles relating to the use of PROMs in the oral mucosal diseases literature was performed in November 2013. In total, 131 articles met the inclusion criteria; these articles addressed the following oral mucosal conditions: lichen planus (75); recurrent aphthous stomatitis (30); mucous membrane pemphigoid/pemphigus vulgaris (14); orofacial granulomatosis (1); and multiple oral mucosal diseases (11). The most commonly used instruments were visual analog scales (VAS) and the oral health impact profile (OHIP). Limited progress has been achieved with use of PROMs in Oral Medicine in the last few decades in both clinical practice and a research setting. With the engagement of allied medical disciplines in PROM usage and the promotion of PROMs by national health care bodies globally, advancement of PROMs is imperative for Oral Medicine. Exposure through the World Workshop on Oral Medicine (WWOM), along with potential involvement in the Core Outcome Measures in Effectiveness Trials (COMET) or other such initiatives, will enable worldwide collaboration to promote the development and utilization of valid and reliable PROMs in oral medicine, and improve patient care.
... Cristina Beza, Daniela Ugliettia, Federica Demarosia, Giovanni Lodia, Andrea Sardellaa, Sonia... more ... Cristina Beza, Daniela Ugliettia, Federica Demarosia, Giovanni Lodia, Andrea Sardellaa, Sonia Viscardia, Antonio Carrassia ... The diagnosis of BMS was based on a patient's symptoms referred to as: spontaneous burning, sting-ing or itching sensation, oral dryness, oral ...
... In numerose riviste sono pub-blicate le linee guida di tale pro-filassi, riportate estesament... more ... In numerose riviste sono pub-blicate le linee guida di tale pro-filassi, riportate estesamente anche sul British National For-mulary e sulla sua edizione ita-liana, curata dall'Agenzia Italia-na del Farmaco (8). ... endocarditis, prosthetic valves and pulmonary or systemic shunts. ...
Oral mucositis is one of the most frequent and significant complications in patients undergoing b... more Oral mucositis is one of the most frequent and significant complications in patients undergoing bone marrow transplantation (BMT). 1 Many agents of differing mechanisms of action 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ...
Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1999
Objective. The aim of this open trial was to test the efficacy of granulocyte-macrophage colony-s... more Objective. The aim of this open trial was to test the efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthrinses as a potential treatment in reducing the duration of severe oral mucositis in patients undergoing bone marrow transplantation for hematologic malignancies. Study Design. The study group was composed of 10 consecutive patients suffering from severe oral mucositis during bone marrow transplantation procedures.
... riesgo. AGRADECIMIENTOS. Los revisores desean agradecer a Chiara Procchio por su ayuda durant... more ... riesgo. AGRADECIMIENTOS. Los revisores desean agradecer a Chiara Procchio por su ayuda durante la mayor parte del trabajo. A Elena Telaro, Emma Tavender, Helen Worthington y Marco Esposito por su apoyo continuo. A ...
... Lodi, DDS, PhD; Antonio Carrassi, MD Milano. 1. Hiroki A, Nakamura S, Shinohara M, et al. Sig... more ... Lodi, DDS, PhD; Antonio Carrassi, MD Milano. 1. Hiroki A, Nakamura S, Shinohara M, et al. Significance of oral examination in chronic graft-versus-host disease. Oral Pathol Med. 1994;23:209-215. FULL TEXT | WEB OF SCIENCE | PUBMED. 2. Schubert MM, Sullivan KM. ...
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2015
This systematic review aimed to (1) explore the patient-reported outcome measures (PROMs) current... more This systematic review aimed to (1) explore the patient-reported outcome measures (PROMs) currently used in the oral mucosal disease literature and report on the type and context of the use of these instruments and (2) provide a future direction for PROMs in Oral Medicine practice and research. A systematic review of published English-language articles relating to the use of PROMs in the oral mucosal diseases literature was performed in November 2013. In total, 131 articles met the inclusion criteria; these articles addressed the following oral mucosal conditions: lichen planus (75); recurrent aphthous stomatitis (30); mucous membrane pemphigoid/pemphigus vulgaris (14); orofacial granulomatosis (1); and multiple oral mucosal diseases (11). The most commonly used instruments were visual analog scales (VAS) and the oral health impact profile (OHIP). Limited progress has been achieved with use of PROMs in Oral Medicine in the last few decades in both clinical practice and a research setting. With the engagement of allied medical disciplines in PROM usage and the promotion of PROMs by national health care bodies globally, advancement of PROMs is imperative for Oral Medicine. Exposure through the World Workshop on Oral Medicine (WWOM), along with potential involvement in the Core Outcome Measures in Effectiveness Trials (COMET) or other such initiatives, will enable worldwide collaboration to promote the development and utilization of valid and reliable PROMs in oral medicine, and improve patient care.
Uploads
Papers by Giovanni Lodi